ArticleACS omega2025
Hydrophobicity-Driven Disruption Mechanism in Kindlin-3 Induced by Leukocyte Adhesion Deficiency Mutation.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukocyte adhesion deficiency type III (LAD-III) is caused by amino acid mutations in Kindlin-3, which result in integrin activation defects. The QW motif in the Kindlin family is particularly important for integrin activation, and the Q595P mutation in the QW motif of Kindlin-3 leads to LAD-III. However, the molecular mechanisms underlying this disruption remain unclear. In this study, we employed molecular dynamics (MD) and steered MD simulations to investigate how the pathogenic Q595P mutation in Kindlin-3 alters its interaction with β1-integrin under physiological conditions. Our results show that the Q595P mutation induces conformational changes in neighboring residues, leading to a reduction in binding affinity, specificity, and mechanical strength, primarily driven by hydrophobic changes. Specifically, the Q595P mutation disrupts the torsional dynamics of residues at the Kindlin-3 binding interface by disturbing the hydrophobic environment, weakening the hydrogen bonds that are essential for stabilizing the Kindlin-3/β1-integrin interaction under both forceful and nonforceful conditions. Additionally, it enhances nonspecific hydrophobic interactions on nonbinding surfaces, further destabilizing the overall binding. These findings provide important insights into the molecular mechanisms by which pathogenic mutations in conserved regions of Kindlin-3 lead to integrin activation defects and contribute to the pathogenesis of LAD-III.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.